Skip to content

Organogenesis Holdings Inc. ORGO Other income, net (Note 6)

Other income, net (Note 6) at other companies

IAR
Integra LifeSciencesIART
$4.48M+3,211%
MiMedx Group logo
MiMedx GroupMDXG
-$168K-15.9%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$734K-159%
Bioventus logo
BioventusBVS
$427K+155%
Axogen logo
AxogenAXGN
$23K+162%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$127K-6,450%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s other income, net (note 6)?
Organogenesis Holdings Inc. (ORGO) reported other income, net (note 6) of $38K in Q1 2026.
How has Organogenesis Holdings Inc.'s other income, net (note 6) changed year-over-year?
Organogenesis Holdings Inc.'s other income, net (note 6) increased by 1800.0% year-over-year, from $2K to $38K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.